Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leadership & People

Set Alert for Leadership & People

‘Challenges Ahead’ For Cell And Gene Therapy, Notes Catapult’s New Chairman McCubbin

The ex-GSK supply head Ian McCubbin will join the independent UK organization aimed at advancing cell and gene therapies, but notes issues with scale and manufacturing ahead.

Executive Changes Personalized Medicine

Sanofi India Chief Departs, Sets Transformative Path

Sanofi India's managing director is moving on after an eventful innings that saw the company re-orient operations, moving out of certain non-strategic areas to focus on core therapies. Pre-pandemic early digital adoption appears to have played out well too for the French group’s listed Indian arm.

Commercial India

Bayer Pharma R&D Head Tackles Challenge Of Prioritizing Promising Assets

Nearly a year into the job, research chief Christian Rommel tells Scrip he is impressed with Bayer's arm's length approach to running acquired firms like AskBio and BlueRock and the task ahead is to deliver on the potential they offer, while getting later-stage projects across the approvals finishing line.

Leadership Clinical Trials

Executives On The Move: Changes At AN2 Therapeutics, Cabaletta Bio And More

C-suite changes at Omega Therapeutics and promotions at Cabaletta Bio are among recent executive changes in the industry. Meanwhile, new directors were appointed at AN2 Therapeutics, among others.

BioPharmaceutical Executive Changes

Executives On The Move: Changes At GlaxoSmithKline, aTyr Pharma And More

Recent executive changes in the industry include the appointment of a new vice president of human resources at aTyr Pharma and promotions at Zhejiang Shapuaisi Pharmaceutical. Meanwhile, new directors were appointed at GlaxoSmithKline and Dicerna Pharmaceuticals, among others.

BioPharmaceutical Executive Changes

Executives On The Move: Changes At Genor, Tenaya And More

A new secretary appointed at Genor Biopharma and promotions at Zai Lab are among recent executive changes in the industry. Meanwhile, new directors were appointed at Tenaya Therapeutics, among others.

BioPharmaceutical Executive Changes

Executives On The Move: New CEO For Aerie Pharmaceuticals

Rajkumar Kannan now leads Aerie, while other changes include former Genentech exec Saraswati Kenkare-Mitra joining Alector as head of R&D and Theresa LaVallee, formerly of Celldex Therapeutics, joining Coherus BioSciences as chief development officer.

Executive Changes BioPharmaceutical

Executives On The Move: Changes At Exicure, Biofrontera And More

C-Suite changes at Iterium Therapeutics and promotions at Exicure are among recent executive changes in the industry. Meanwhile, new board members were appointed at Biofrontera, among others.

BioPharmaceutical Executive Changes

Executives On The Move: Changes At AbCellera Biologics, Decibel Therapeutics And More

C-Suite changes at AbCellera Biologics and promotions at Lyell Immunopharma are among recent executive moves in the industry. Meanwhile, new directors were appointed at Decibel Therapeutics, Curis and Ventus Therapeutics, among others.

Executive Changes Leadership

Novartis Poised To Grow Despite $9bn In LOEs Coming, CEO Says

CEO Vas Narasimhan committed to delivering compound annual growth of 4% from 2020-2026, driven by newer brands plus some pipeline assets.

Business Strategies Generic Drugs

Executives On The Move: Changes At Acceleron, Faron Pharmaceuticals And More

C-suite changes at Relief Therapeutics and promotions at Black Diamond Therapeutics are among recent executive changes in the industry. Meanwhile, new directors were appointed at Adagio Therapeutics, OKYO Pharma and Tenaya Therapeutics, among others.

Executive Changes Leadership

India’s 'Thousand Talents' Moment And Models To Shift Gears In R&D

Industry leaders including Sanofi's ex-CEO and the chiefs of Sun, Lupin, Glenmark, Dr Reddy’s and Cipla discuss how India could leapfrog its pharma R&D efforts. Could the South Korea model or a hybrid approach including bringing back top talent bolster the country’s efforts to emerge as a global innovation hot spot?

India Research & Development
See All
UsernamePublicRestriction

Register